Andromeda Surgical Analysis: $500K Raised
What is Andromeda Surgical?
Andromeda Surgical is building an intelligence layer for surgery, starting with endourology and robotic-assisted HoLEP. Its platform uses AI-guided spatial navigation, a tablet interface, and surgeon-in-the-loop autonomy to support procedure execution. The company says it performed the world’s first robotic-assisted HoLEP procedure in 2024 and has begun clinical testing through ASTRA.
Location
101 Mississippi St, San Francisco, California 94107, United States
Employees
1-10
Founded
2023
Revenue
$1.5M
Business Model
AI-assisted surgical robots with revenue from partnerships and funding rounds.
Product Features & Capabilities
- AI-guided surgical robot, enhanced accuracy in endourology, efficiency boost to reduce operating room time, user-friendly interface designed for surgeons.
How much Andromeda Surgical raised
1 - $500K
April 1, 2023Lead Investor: Y Combinator, WestWave Capital, and 4 others
Who are the founders of Andromeda Surgical
ND
Nick Damiano
Co-Founder & CEO
KT
Kartik Tiwari
Co-Founder & CTO
Market Focus
Andromeda Surgical primarily focuses on the medical technology industry, specifically in the field of robotic surgery and endourology, utilizing AI guidance to enhance surgical accuracy and patient outcomes.
Competitors Overview
Andromeda Surgical operates in the robotic surgery market, particularly focusing on endourology with AI-assisted technology. Its main competitors include:
-
Intuitive Surgical: Known for its da Vinci surgical system, Intuitive Surgical is a leader in robotic surgery. Its systems are widely used in various surgical procedures, including urology. The da Vinci system is recognized for its precision and has a strong market presence, but it may not utilize AI to the same extent as Andromeda Surgical's offerings.
-
Medtronic: This company is a significant player in the surgical robotics field, offering various robotic-assisted surgical systems. Medtronic's systems are designed for a range of surgical applications, including urology. However, they may not focus as heavily on AI guidance as Andromeda Surgical.
-
CMR Surgical: A newer entrant, CMR Surgical is developing the Versius robotic system, which is designed to be versatile and cost-effective. It aims to compete directly with established players like Intuitive Surgical. CMR's focus on affordability and accessibility may provide a competitive edge in certain markets.
-
Johnson & Johnson: Their new robotic surgical system, Ottava, is designed to compete with Intuitive Surgical's da Vinci system. Johnson & Johnson's extensive resources and market reach could pose a significant challenge to Andromeda Surgical.
-
Moon Surgical: This company is also entering the U.S. market with innovative robotic systems, focusing on enhancing surgical capabilities. Their approach may differ from Andromeda's, particularly in terms of technology and market strategy.
Notable differences for Andromeda Surgical include its emphasis on AI guidance, which aims to enhance surgical accuracy and outcomes, potentially setting it apart from competitors that may not leverage AI to the same extent.
Investors
- Y Combinator
- CoreNest
- WestWave Capital
- 468 Capital
- Alumni Ventures
- BBQ Capital
- Hatcher+
- Pioneer Fund
- Attack Capital
See something that needs updating? Suggest edits to this profile.